3-amino-1-methyl-1H-pyrazole-4-carboxamide, 95%, 100mg

N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide, 95.0%, 1g

N-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-amine, 95.0%, 250mg

5-Chloro-2-nitrobenzoic acid, min. 98%, for synthesis, 100 g, plastic packaging.

6-Methyl-imidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 1g

TERT-BUTYL 6,7-DIHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-CARBOXYLATE, 95.0%, 250mg

Accessories exchange block for reaction vessels, Gesch. for, 15 Reaction vials 5 ml (max. 1200 min-1), 1 piece

1,4-Dichloro-2-butanol>97.0%(GC)5g

(2S)-1-BENZYL 2-METHYL 4-HYDROXYPIPERIDINE-1,2-DICARBOXYLATE, 95.0%, 5g

3,4-Dimethylbenzylsulfonyl chloride, 1g

4-(tert-Butyl)-1,2-diaminobenzene, 97.0%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)non-8-enoic acid, 95.0%, 5g

methyl 3-amino-4-(tert-butyl)benzoate, 95.0%, 250mg